256 related articles for article (PubMed ID: 35017025)
1. The impact of protein corona on the biological behavior of targeting nanomedicines.
Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
[TBL] [Abstract][Full Text] [Related]
2. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
4. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
5. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
6. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
[TBL] [Abstract][Full Text] [Related]
7. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
8. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
[TBL] [Abstract][Full Text] [Related]
9. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
10. Protein corona: challenges and opportunities for targeted delivery of nanomedicines.
Jiang Z; Chu Y; Zhan C
Expert Opin Drug Deliv; 2022 Jul; 19(7):833-846. PubMed ID: 35738018
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
Kamaly N; Farokhzad OC; Corbo C
Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
[TBL] [Abstract][Full Text] [Related]
12. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
Song D; Xu Q
Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the analysis of nanoparticle-protein coronas.
Ovais M; Nethi SK; Ullah S; Ahmad I; Mukherjee S; Chen C
Nanomedicine (Lond); 2020 Apr; 15(10):1037-1061. PubMed ID: 32248745
[TBL] [Abstract][Full Text] [Related]
14. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
Wang Y; Cai R; Chen C
Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
[TBL] [Abstract][Full Text] [Related]
15. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
16. Pay Attention to Biological Nanoparticles when Studying the Protein Corona on Nanomedicines.
Simonsen JB; Münter R
Angew Chem Int Ed Engl; 2020 Jul; 59(31):12584-12588. PubMed ID: 32347625
[TBL] [Abstract][Full Text] [Related]
17. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
Fasoli E
Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
Nienhaus K; Nienhaus GU
Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
[TBL] [Abstract][Full Text] [Related]
19. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
Aliyandi A; Zuhorn IS; Salvati A
Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
[TBL] [Abstract][Full Text] [Related]
20. Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona.
Li Z; Wang Y; Zhu J; Zhang Y; Zhang W; Zhou M; Luo C; Li Z; Cai B; Gui S; He Z; Sun J
J Control Release; 2020 Apr; 320():1-18. PubMed ID: 31931050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
